Vaccine
Phase 3Completed 0 watching 0 views this week๐ Rising
69
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza
Conditions
Influenza
Trial Timeline
Nov 28, 2016 โ Mar 25, 2017
NCT ID
NCT02935192About Vaccine
Vaccine is a phase 3 stage product being developed by Comac Medical for Influenza. The current trial status is completed. This product is registered under clinical trial identifier NCT02935192. Target conditions include Influenza.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02935192 | Phase 3 | Completed |
Competing Products
20 competing products in Influenza